Icosavax Inc. (ICVX)
NASDAQ: ICVX
· Real-Time Price · USD
15.31
-0.14 (-0.91%)
At close: Feb 16, 2024, 10:00 PM
Icosavax Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.73M | 1.83M | 1.9M | 2M |
Cost of Revenue | 763K | 665K | 643K | 1.6M | 143K | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -763K | -665K | -643K | -1.6M | -143K | n/a | n/a | -5.73M | 1.83M | 1.9M | 2M |
Operating Income | -25.27M | -28.95M | -26.52M | -25.13M | -23.14M | -23.13M | -23.65M | -18.21M | -34.41M | -8.59M | -4.64M |
Interest Income | 3.23M | 2.46M | 1.96M | 1.52M | 1.17M | 495K | 120K | 29K | n/a | n/a | n/a |
Pretax Income | -22.04M | -26.5M | -24.56M | -23.61M | -21.98M | -22.64M | -23.53M | -18.18M | -34.39M | -8.55M | -5.85M |
Net Income | -22.04M | -26.5M | -22.6M | -21.48M | -20.81M | -22.14M | -23.41M | -18.18M | -34.39M | -8.55M | -5.85M |
Selling & General & Admin | 8.61M | 9.13M | 9.16M | 8.94M | 7.66M | 7.31M | 6.32M | 6.22M | 25.36M | 2.22M | 1.09M |
Research & Development | 16.67M | 19.83M | 17.36M | 16.19M | 15.48M | 15.82M | 17.91M | 14.06M | 10.88M | 8.28M | 5.55M |
Other Expenses | n/a | n/a | n/a | 582K | n/a | n/a | -582K | n/a | n/a | n/a | -205K |
Operating Expenses | 25.27M | 28.95M | 26.52M | 25.13M | 23.14M | 23.13M | 23.65M | 18.21M | 34.41M | 8.59M | 4.64M |
Interest Expense | n/a | n/a | n/a | n/a | 1.17M | n/a | 120K | n/a | 27K | 42K | 249K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 25.27M | 28.95M | 26.52M | 25.13M | 23.14M | 23.13M | 23.65M | 18.21M | 34.41M | 8.59M | 4.64M |
Income Tax Expense | n/a | n/a | -1.96M | -2.13M | -1.17M | -495K | -120K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 50.03M | 44.77M | 41.26M | 39.81M | 39.75M | 39.59M | 39.4M | 39.14M | 26.49M | 2.99M | 2.99M |
Shares Outstanding (Diluted) | 50.03M | 44.77M | 41.26M | 39.81M | 39.75M | 39.59M | 39.4M | 39.14M | 26.49M | 2.99M | 2.99M |
EPS (Basic) | -0.44 | -0.59 | -0.55 | -0.54 | -0.52 | -0.56 | -0.59 | -0.46 | -1.3 | -2.86 | -1.96 |
EPS (Diluted) | -0.44 | -0.59 | -0.55 | -0.54 | -0.52 | -0.56 | -0.59 | -0.46 | -1.3 | -2.86 | -1.96 |
EBITDA | -25.27M | -28.95M | -26.52M | -25.13M | -23M | -23.08M | -23.61M | -18.21M | -34.38M | -8.58M | -4.64M |
EBIT | n/a | n/a | -25.2M | -25.75M | -20.81M | -23.13M | -23.41M | -18.31M | -34.36M | -8.51M | -5.6M |
Depreciation & Amortization | 763K | 665K | 643K | 619K | 143K | 55K | 43K | 36K | 29K | 16K | 1K |